Influence of Psychotropic Pro Re Nata Drug Use on Outcomes in Hospitalized Patients with Schizophrenia. [PDF]
Clin Psychopharmacol Neurosci, 2023 In the treatment of patients with schizophrenia, pro re nata (PRN) drugs are commonly prescribed for medical indications such as agitation, acute psychiatric symptoms, insomnia, and anxiety. However, high-quality evidence supporting the use of PRN medications is lacking, and these drugs are administered on the basis of clinical experience and habits ...
Kyou Y +11 more
europepmc +3 more sources
Brolucizumab versus aflibercept in treating exudative age-related macular degeneration: a 12-month pro re nata regimen. [PDF]
Sci RepWe compared 12-month treatment outcomes of intravitreal injections of brolucizumab (IVBr) with aflibercept (IVA) for treatment-naïve exudative age-related macular degeneration (AMD).
Kikushima W +6 more
europepmc +2 more sources
Factors associated with extended remission in neovascular age-related macular degeneration on pro re nata treatment protocol. [PDF]
Br J Ophthalmol, 2020 AimTo show the characteristics and outcomes of patients with neovascular age-related macular degeneration (nAMD) who had extended remission (ER) while on a pro re nata (PRN) treatment protocol.MethodsThis was a retrospective case-control study of a ...
Lin T +6 more
europepmc +3 more sources
Real-world experience with pro re nata dosing of intravitreal dexamethasone implant for eyes with refractory diabetic macular edema. [PDF]
GMS Ophthalmol Cases, 2020 Aims: To evaluate treatment outcomes of pro re nata dosing of intravitreal dexamethasone implant in eyes with refractory diabetic macular edema (DME) amongst Indian subjects.Methods and material: Retrospective, interventional case series. Medical records
Rishi P +4 more
europepmc +2 more sources
Pro Re Nata Use of Psychotropic Medications in Assisted Living [PDF]
Innov Aging, 2020 Abstract This study examined the use of pro re nata (PRN, or as needed) psychotropic medications among assisted living (AL) residents. We examined prescriptions and administrations, and compared use based on dementia diagnosis. Data sources included interviews with administrators of 250 AL communities in 7 states and medication ...
Carder P +4 more
europepmc +3 more sources
Impact of psychotropic pro re nata prescription-monitoring programme on prescriptions for inpatients with psychiatric disorders: a retrospective observational study. [PDF]
BMC PsychiatryBackground Pro re nata (PRN) medication is used “as needed” for symptoms such as agitation and insomnia, in addition to regular daily pharmacotherapy of mental disorders. However, there is no high-quality evidence on the effectiveness of psychotropic PRN
Saito Y +10 more
europepmc +2 more sources
Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical Practice. [PDF]
Ophthalmol TherIntroduction Anti-vascular endothelial growth factor (VEGF) is generally given using pro re nata or “treat-and-extend” (T&E) regimens for neovascular age-related macular degeneration (nAMD).
Debourdeau E +12 more
europepmc +2 more sources
Prevalence and types of medication errors in pro re nata medication orders among hospitalized patients: a cross-sectional study. [PDF]
J Pharm Health Care SciBackground Medication errors in Pro Re Nata (PRN) prescriptions pose a significant threat in hospital settings, especially due to unclear prescribing practices.
Rasouli-Rad A +6 more
europepmc +2 more sources
'To give or not to give medication, that is the question.' Healthcare personnel's perceptions of factors affecting pro re nata medication in sheltered housing for older adults - a focus-group interview study. [PDF]
BMC Health Serv Res, 2020 Background Residents living in sheltered housing depend on help from healthcare personnel (HCP) with medication management, regarding regular long-term and pro re nata (PRN) medication.
Nilsen MK, Sletvold H, Olsen RM.
europepmc +2 more sources